Doing Today’s Work Today in Healthcare
- Dr. Warren Brown
- 7 days ago
- 2 min read

Want to reverse the trend in escalating medical costs? Start by reducing avoidable inpatient utilization for heart attack, stroke, and heart failure through earlier identification and management of chronic underlying conditions such as obesity, diabetes, hypertension, and hyperlipidemia. This is not a groundbreaking strategy, but few have executed it well. Success requires removing barriers that delay access to high-value care, especially primary care, and eliminating administrative and financial complexity when members engage early. Concierge-level support should make PROACTIVE CARE easier and more rewarding for both members and providers. Providers need fewer administrative burdens, adequate time with patients, and appropriate reimbursement to deliver high-value care effectively. Payors can accelerate this by building a branded marketplace that aligns motivated members, motivated providers, and benefits designed to reward early action. The clinical and financial return is real: reversing prediabetes has been shown to reduce cardiovascular mortality by more than 50%, with benefits lasting decades (Vazquez Arreola et al., 2025), and cardiometabolic risk factors such as high blood pressure and glucose intolerance are strongly associated with increased mortality across chronic disease populations (Dukewich et al., 2025). Doing today’s work today lowers total cost, improves outcomes, and creates shared value. Tomorrow is only more expensive.
Vazquez Arreola, E., Gong, Q., Hanson, R. L., et al. (2025). Prediabetes remission and cardiovascular morbidity and mortality: Post-hoc analyses from the Diabetes Prevention Program Outcome Study and the DaQing Diabetes Prevention Outcome Study. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/S2213-8587(25)00295-5
Dukewich, M., Dodge, J. L., Yuan, L., & Terrault, N. A. (2025). Differential effects of cardiometabolic risk factors on all-cause mortality in U.S. adults with metabolic dysfunction-associated steatotic liver disease (MASLD). Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2025.09.003







Comments